Q2 FY27 earnings call · November 10, 2026
Sigma Advanced System Ltd (SIGMAADV) Q2 FY27 Earnings Call: Order Book Crosses Rs. 10,000 Cr, Targets Rs. 2,000 Cr FY27 Revenue
Listen to the earnings call
Quick summary
Sigma Advanced System Ltd held its Q2 FY27 earnings call on November 06, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.
Solid Sequential Growth; PAT Up Sharply QoQ
- Q2 FY 2026-2027 revenue of Rs.417 crore — up 11.43% QoQ from Rs.374 crore in Q1 FY 2026-2027 (management also cited ~12-13% sequential growth).
- Operating EBITDA of Rs.82.28 crore at 19.7% margin — versus Rs.61 crore in Q1 FY 2026-2027, a clear sequential margin lift.
- PAT (ex-associate share) of Rs.48.6 crore — up from Rs.35.41 crore in Q1 FY 2026-2027.
- H1 FY 2026-2027 revenue of Rs.800+ crore — management expects a ~Rs.1,200 crore ramp over H2 (Q3-Q4) toward the Rs.2,000 crore full-year FY 2026-2027 target, noting the industry-wide Q3-Q4 skew typical of Indian defense companies.
- Targeted UK capex and working capital investments — aimed at automation and process efficiency; management expects further efficiencies (period unspecified).
Rs.10,000+ Cr Book, Rs.3,915 Cr of New Wins, NATO Door Open
- Order book of Rs.10,000+ crore as of the call date — 90% international, which management cited as giving strong long-term visibility.
- Rs.3,915 crore of new orders announced from July 1, 2026 to the call date (FY 2026-2027 to date) — largely executable over 12-18 months, with contributions starting Q3-Q4 FY 2026-2027.
- Defense exports order book of Rs.2,700 crore as of Q2 FY 2026-2027 — described by the Group CEO as one of the largest defense export order books in the country.
- Supplier-of-choice status and NATO entry — on-time Q1/Q2 FY 2026-2027 execution won repeat orders tied to delivery milestones and opened the NATO order book, with discussions ongoing with additional new NATO customers.
- Management expects order books to keep rising over the medium term — citing ongoing global conflicts, restockpiling requirements, and NATO defense budgets going up as announced.
- M107 export order ~85% revenue-recognized — for the order announced June 8, 2026 (analyst-cited at 40,000 shells, 6-month execution completing December), the remaining 15% completed in October and will reflect in Q3 FY 2026-2027 results.
- Component-level orders, not full-solution contracts — announced orders cover fuses or shell bodies individually; Sigma offers the full ammunition platform except the explosive fill.
CCT Utilization at 10-15%; India Work Transfer Underway
- CCT utilization at 10-15% as of Q2 FY 2026-2027 — operations commenced Q1 FY 2026-2027; management expects utilization to rise ~10% every quarter, though no end-FY27 level was quantified.
- Work-split target of 30% UK / 70% India — steady-state target (period unspecified) for the transferred work.
- Sri City Phase 1 guided to ~50-60% utilization by end of FY28 — rising to full capacity by FY29; production commenced September 2026 and parts are already rolling out to the UK and onward to customers.
- UK-to-India work transfer began last month (FY 2026-2027) — management emphasized "We already have the orders"; no new orders are needed to fill the factory.
- 15-20% annual YoY aerospace growth expected (period unspecified), with the Tri-City facility expected to ramp ~15% per quarter (period unspecified); the aerospace order book is a long-term executable contract book running across seven UK factories, with stable, high-visibility delivery for the next 5 to 7 years.
- Defense is ~25-30% of UK revenue (Bromford and Naismith) as of Q2 FY 2026-2027 — highly restrictive, profitable work supplying Lockheed Martin, Airbus defense programs, BAE Systems and Rheinmetall that management says cannot be moved elsewhere; Sigma is a classified Tier 1 supplier directly contracting Rolls-Royce, GE, Airbus and Boeing.
- India factory will operate as a sub-contractor to Sigma UK — the aerospace P&L will continue to run through Sigma UK in published numbers (Pramod Raju).
OTIF at ~97%; Aerospace Margin Bridge to Indian-Peer Levels by FY28
- OTIF delivery improved from 65% to ~97% — over the last few quarters through Q2 FY 2026-2027, following ~£8-9mn of post-acquisition investment in Naismith and Bromford (working capital plus capex on new equipment kits).
- Sigma UK EBITDA margin delivered at least a 200% per-quarter improvement (as stated) from Q3 FY 2025-2026 to Q2 FY 2026-2027, driven by the investments and insourcing of work; the quarterly improvement trend is expected to continue through Q3-Q4 FY 2026-2027.
- Aerospace EBITDA margin guided to 25-30% by FY28 — CEO: "possible... 25 to 30% is what we should look at"; Pramod Raju affirmed FY28 at 25-30%, in response to the analyst citing defense's current 22-30% range.
- Margin bridge to FY28 — Western aerospace operations run at upper single-digit EBITDA margins absent automation/capex; management expects aerospace EBITDA margin to be in line with Indian peers by FY28 while maintaining a UK base of ~500+ employees.
- Q2 FY 2026-2027 defense exports margins expanded much stronger — despite slightly smaller Q2 M107 sales, driven by supply-chain changes and higher in-house content.
- No new capex required — all capex for the facilities is already invested and visible in the Q2 FY 2026-2027 balance sheet; management sees no capacity constraint and is positioned to execute the existing order book "for the next couple of years."
- Capacity headroom as of Q2 FY 2026-2027 — aerospace in India at ~15%, shells/ammunition at ~20%, defense electronics on a single shift during infrastructure expansion.
Rs.3,000 Cr Raise Aimed at $100-150mn Revenue Targets
- Plan to raise up to Rs.3,000 crore, primarily for M&A — subject to shareholder approval in due course, with potential progress flagged for Q4 FY 2026-2027; management has worked on multiple acquisition opportunities over the last 6-8 months and expects to close transactions in Q4 FY 2026-2027.
- Target profile of roughly $100-150 million revenue scale (period unspecified) — spread across different customers and capability sets; per Pramod Raju, targets must have a good customer base and be EBITDA-positive — no loss-making or sick companies.
- Acquisitions being evaluated across all three geographies — including Europe and the US beyond the completed UK acquisitions; per the Q1 FY 2026-2027 investor meet, the company is building a global platform over the next two-three years via horizontal and vertical integration and customer penetration.
- Balance sheet: ~Rs.350 crore cash as of Q2 FY 2026-2027 — partly from the June preferential placement; debt minimal at ~Rs.80 crore (borrowed from the parent for previous acquisitions); H1 debt increase is working-capital driven and in line with industry standards.
- Preferential issue funds temporarily parked in fixed deposits — CFO Sridat Sathacharya clarified the bank balances under operating adjustments in the Q2 FY 2026-2027 cash flow statement are interim parking and can be read as a financing item; no deployment timeline was specified.
- Rs.76 crore of term loans have no finalized repayment strategy yet (period unspecified); other term borrowings on the H1 FY 2026-2027 balance sheet are scheduled for payback from January 1 to December 31, calendar 2027.
- Nismat Group clarification — responding to an analyst citing ~Rs.250 crore purchase price and Rs.750 crore top line, Kalidindi said the company was already EBITDA-positive the day Sigma took over, its financial stress predated the acquisition, and Sigma has since driven incremental improvements.
FY27 Target Near Rs.1,900-2,000 Cr; ~90% Export Mix
- FY 2026-2027 revenue targeted at close to Rs.1,900-2,000 crore with ~20% EBITDA margin — with EBITDA margin improvement of 200-400 bps by end of FY27 and a further 400-600 bps by end of FY28 as select manufacturing transitions to India.
- Revenue mix guided at ~90% export-driven vs ~10% domestic for FY 2026-2027 — GBP/USD/EUR-denominated global contracts; management declined to give an FY27/FY28 export breakdown or facility/entity-level split.
- Domestic defense at only ~3-4% of the mix (figure cited in the analyst's question) — Kalidindi said it remains a strategic focus, involves building full solutions, carries a healthy margin profile, and will continue to grow.
- Counter-drone leadership — Sigma is "one of the leaders in the country" in Counter Drone Solutions, with successful supplies to the Army and Navy; a large BSF contract — the largest in the country under MSA (Ministry of Home Affairs) for BSF — is under execution, and management cited a good pipeline plus a capability unique to Sigma to supply these systems overseas with all certifications from NASM.
- Exclusive CCF MOU with Munitions India Limited — technology developed by Sigma's European joint-venture partner, in testing since 2017, field-tested and combat-deployed across Europe and America, and indigenized into India for offer to MIL on an exclusive basis; management expects actual supply to MIL within 6-18 months (i.e., supplies expected from FY 2027-2028 onward).
- Management declined to quantify aerospace work moving to India by FY28 — it gives only a one-two quarter maximum outlook; quantum updates to be shared Q on Q. Management also declined to break out the order book by customer, citing NDAs.
- Industry context cited by management — global aerospace OEMs are increasingly looking to India for engineering depth and scale beyond cost advantage; NATO and allied nations are strengthening ammunition manufacturing capacity and require dependable supply-chain partners; the Government of India continues to emphasize indigenous defense manufacturing.
Ask about this
Ask Cofacto a question about this call. Answers cite filings and company data.
Companies on this page
Related
Disclaimer: This earnings call summary is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.